Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity
Photon radiation therapy is a major curative treatment for cancer. However, the lack of robust predictive biomarkers for radiosensitivity precludes personalized radiation therapy. Clonogenic assays are the gold standard method for measuring the radiosensitivity of cancer cells. Although a large numb...
Main Authors: | Toshiaki Matsui, Endang Nuryadi, Shuichiro Komatsu, Yuka Hirota, Atsushi Shibata, Takahiro Oike, Takashi Nakano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/17/4148 |
Similar Items
-
Comparison of Clonogenic Survival Data Obtained by Pre- and Post-Irradiation Methods
by: Takahiro Oike, et al.
Published: (2020-10-01) -
Radiosensitivity Differences between <i>EGFR</i> Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses
by: Mai Anakura, et al.
Published: (2019-07-01) -
Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells
by: Kim Han, et al.
Published: (2012-07-01) -
Miniaturization of the Clonogenic Assay Using Confluence Measurement
by: Christian Mayr, et al.
Published: (2018-03-01) -
The clonogenic assay: robustness of plating efficiency-based analysis is strongly compromised by cellular cooperation
by: Nikko Brix, et al.
Published: (2020-10-01)